Telix Pharmaceuticals US
Diagnostic radiopharmaceutical providing precision medicine to patients in the U.S.
Based in IN
AI Overview
With $52K in lobbying spend across 3 quarterly filings, Telix Pharmaceuticals US is an active lobbying client. Their lobbying covers 3 issue areas.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2025 | $52K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Telix Pharmaceuticals US disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Medicare/Medicaid, MED
Medicare reimbursement; working with Congress on legislation relating to the early detection and treatment of deadly diseases.
Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.